January 12, 2023 Sophia Vida

Odyssey Health, Inc. To Develop Intranasal Field- Deliverable Nerve Agent Antidote

Las Vegas, NV, January 12, 2023 — McapMediaWire — Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, announces the launch of a concept phase to develop an intra-nasal field-deliverable nerve agent antidote. Chemical warfare using organophosphate nerve agents is a threat worldwide. The risk could … Continue reading “Odyssey Health, Inc. To Develop Intranasal Field- Deliverable Nerve Agent Antidote”